DoW Ovarian Cancer, Clinical Trial Award
DOD-AMRAA Posted HT942526OCRPCTA
Close Date:
October 1, 2026
60 days remaining
Description
Summary: The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer. Distinctive Features: Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations.
Actions
Funding Details
- Award Floor
- Not specified
- Award Ceiling
- Not specified
- Total Estimated Funding
- $5,600,000.00
- Expected Awards
- 2
Key Dates
- Posted
- May 4, 2026
- Closes
- October 1, 2026 60d
- Archive Date
- October 31, 2026
Agency Information
- Agency Name
- Defense Health Agency Contracting Activity - DHACA
- Agency Code
- DOD-AMRAA
- Funding Instrument
- Other